TipRanks
Larimar Therapeutics, Inc. (DE:ZA71)
FRANKFURT:ZA71
Germany Market
ZA71
Larimar Therapeutics
RESEARCH TOOLSreports

Larimar Therapeutics (ZA71) Balance Sheet

3 Followers

Larimar Therapeutics Balance Sheet

Larimar Therapeutics's total assets for Q2 2026 were $165.30M, a decrease of -20.72% from the previous quarter. DE:ZA71 total liabilities were $37.92M for the fiscal quarter, a -24.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 145.84M$ 200.22M$ 95.94M$ 126.41M$ 78.67M
Total Liabilities
$ 67.76M$ 28.41M$ 14.21M$ 15.50M$ 14.25M
Total Equity Gross Minority
$ 78.08M$ 171.81M$ 81.72M$ 110.90M$ 64.41M
Other Metrics
Currency in USD

Larimar Therapeutics Debt to Assets